These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19895739)

  • 21. Monoclonal antibody Adnab-9 defines a preneoplastic marker in epithelium at risk for adenocarcinoma of the small intestine.
    Tobi M; Kaila V; Hassan N; Gallinger S; Fligiel S; Hatfield J; Gesell M; Sakr W; Luk G; Odze RD
    Hum Pathol; 1999 Apr; 30(4):467-73. PubMed ID: 10208470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased levels of promutagenic etheno-DNA adducts in colonic polyps of FAP patients.
    Schmid K; Nair J; Winde G; Velic I; Bartsch H
    Int J Cancer; 2000 Jul; 87(1):1-4. PubMed ID: 10861445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced cyclooxygenase-2 expression in sporadic and familial adenomatous polyposis of the human colon.
    Khan KN; Masferrer JL; Woerner BM; Soslow R; Koki AT
    Scand J Gastroenterol; 2001 Aug; 36(8):865-9. PubMed ID: 11495083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
    Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
    BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometric analysis of DNA synthetic phase fraction of the normal appearing colonic mucosa in patients with colorectal neoplasms.
    Nakamura S; Goto J; Kitayama Y; Sheffield JP; Talbot IC
    Gut; 1995 Sep; 37(3):398-401. PubMed ID: 7590437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical characteristics of duodenal adenomas in familial adenomatous polyposis with special reference to cell kinetics.
    Esaki M; Matsumoto T; Yao S; Nakamura S; Hirahashi M; Yao T; Iida M
    Hum Pathol; 2005 Jan; 36(1):66-73. PubMed ID: 15712184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic and transcriptomic profiling of carcinogenesis in patients with familial adenomatous polyposis.
    Li J; Wang R; Zhou X; Wang W; Gao S; Mao Y; Wu X; Guo L; Liu H; Wen L; Fu W; Tang F
    Gut; 2020 Jul; 69(7):1283-1293. PubMed ID: 31744909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients.
    Sinicrope FA; Half E; Morris JS; Lynch PM; Morrow JD; Levin B; Hawk ET; Cohen DS; Ayers GD; Stephens LC;
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):920-7. PubMed ID: 15184247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microenvironmental changes in familial adenomatous polyposis during colorectal cancer carcinogenesis.
    Hisano K; Mizuuchi Y; Ohuchida K; Kawata J; Torata N; Zhang J; Katayama N; Tsutsumi C; Nakamura S; Okuda S; Otsubo Y; Tamura K; Nagayoshi K; Ikenaga N; Shindo K; Nakata K; Oda Y; Nakamura M
    Cancer Lett; 2024 May; 589():216822. PubMed ID: 38521200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical expression of PCNA and CD34 in colorectal adenomas and carcinomas using specified automated cellular image analysis system: a clinicopathologic study.
    Qasim BJ; Ali HH; Hussein AG
    Saudi J Gastroenterol; 2012; 18(4):268-76. PubMed ID: 22824771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of a low-dose nonsteroidal anti-inflammatory drug regimen in reversing adenomas exceeding 33 months.
    Winde G; Schmid KW; Schlegel W; Fischer R; Osswald H; Bünte H
    Dis Colon Rectum; 1995 Aug; 38(8):813-30. PubMed ID: 7634976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression and significance of APC, beta-catenin, C-myc, and Cyclin D1 proteins in colorectal carcinoma].
    Dai WB; Ren ZP; Chen WL; DU J; Shi Z; Tang DY
    Ai Zheng; 2007 Sep; 26(9):963-6. PubMed ID: 17927853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of COX-2 and Wnt pathway genes in adenomas of familial adenomatous polyposis patients treated with meloxicam.
    Dobbie Z; Muller PY; Heinimann K; Albrecht C; D'Orazio D; Bendik I; Müller H; Bauerfeind P
    Anticancer Res; 2002; 22(4):2215-20. PubMed ID: 12174906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. hMLH1, hMSH2 and cyclooxygenase-2 (cox-2) in sporadic colorectal polyps.
    Balbinotti RA; Ribeiro U; Sakai P; Safatle-Ribeiro AV; Balbinotti SS; Scapulatempo C; Alves VA; Corbett CE; Carrilho FJ
    Anticancer Res; 2007; 27(6C):4465-71. PubMed ID: 18214062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclooxygenase-2 expression in FAP patients carrying germ line MYH mutations.
    Frattini M; Carnevali I; Signoroni S; Balestra D; Moiraghi ML; Radice P; Varesco L; Gismondi V; Ballardini G; Sala P; Pierotti MA; Pilotti S; Bertario L
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2049-52. PubMed ID: 16103460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimizing the timing of colorectal surgery in patients with familial adenomatous polyposis in clinical practice.
    Vasen HFA; Ghorbanoghli Z; de Ruijter B; Trinidad RA; Langers AMJ; Peeters KCMJ; Bonsing BA; Hardwick JCH
    Scand J Gastroenterol; 2019 Jun; 54(6):733-739. PubMed ID: 31401889
    [No Abstract]   [Full Text] [Related]  

  • 37. Cell proliferation and differentiation in familial adenomatous polyposis (FAP).
    Biasco G
    Hum Pathol; 2004 Dec; 35(12):1573. PubMed ID: 15619221
    [No Abstract]   [Full Text] [Related]  

  • 38. Cell proliferation of the duodenal mucosa in patients affected by familial adenomatous polyposis.
    Santucci R; Volpe L; Zannoni U; Paganelli GM; Poggi B; Calabrese C; Biasco G
    Gastroenterology; 1997 Oct; 113(4):1159-62. PubMed ID: 9322510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The expression of E-cadherin and catenins in colorectal tumours from familial adenomatous polyposis patients.
    El-Bahrawy MA; Talbot IC; Poulsom R; Jeffery R; Alison MR
    J Pathol; 2002 Sep; 198(1):69-76. PubMed ID: 12210065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Adaptive Immune Landscape of the Colorectal Adenoma-Carcinoma Sequence.
    Freitas JA; Gullo I; Garcia D; Miranda S; Spaans L; Pinho L; Reis J; Sousa F; Baptista M; Resende C; Leitão D; Durães C; Costa JL; Carneiro F; Machado JC
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.